BEIJING: Chinese researchers are testing mixing two COVID-19 vaccines developed by CanSino Biologics and a unit of Chongqing Zhifei Biological Products respectively, according to clinical trial registration data.
Earlier this month, the director of the Chinese Center for Disease Control and Prevention said the country was "formally considering" giving people COVID-19 vaccines developed with different technologies as a way of further boosting vaccine efficacy.
A trial expected to involve 120 participants will test the safety and ability to trigger immune response of a dose of CanSinoBIO's Ad5-nCoV treatment, followed by a dose of ZF2001 from Anhui Zhifei Longcom Biopharmaceutical, at 28-day or 56-day interval, according to clinical trial record site ClinicalTrials.gov maintained by a department under the National Institute of Health of the United States.
The trial, under way in the eastern Chinese city of Nanjing, is sponsored by disease control authorities in Jiangsu province, according to the record.
Both vaccines are included in China's mass vaccination drive.
CanSinoBIO said interim data from overseas Phase III clinical trials showed its Ad5-nCoV vaccine was 68.83% effective at preventing symptomatic COVID-19 disease two weeks after one injection, while the rate fell to 65.28% four weeks after one shot.
Chinese researchers are also running trials for two-dose-based vaccination of Ad5-nCoV, as well as an inhalation version of the vaccine.
No efficacy readings has been made available from Phase III trials for Zhifei Longcom's ZF2001 vaccine, which requires three injections when used on its own.
CanSinoBIO and Chongqing Zhifei Biological Products were not immediately available for comment.
Reuters
Mon Apr 19 2021
![China trials mixing of COVID-19 vaccines from CanSinoBIO and Zhifei Longcom - Data China trials mixing of COVID-19 vaccines from CanSinoBIO and Zhifei Longcom - Data](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-04/81618492458_CanSinoBiologics.jpg)
Chinese researchers are also running trials for two-dose-based vaccination of Ad5-nCoV, as well as an inhalation version of the vaccine. REUTERSpic
![Reman suspek kes keropok beracun disambung dua hari Reman suspek kes keropok beracun disambung dua hari](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/81721107133_keropokberacunrem.jpg)
Reman suspek kes keropok beracun disambung dua hari
Tempoh reman terhadap seorang pemilik kebun disambung selama dua hari, bagi membantu siasatan kematian dua kanak-kanak yang meninggal dunia akibat makan keropok beracun.
![Tidak perlu lagi kemas kini status COVID-19 dalam MySejahtera - KKM Tidak perlu lagi kemas kini status COVID-19 dalam MySejahtera - KKM](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/81721100784_TBmysj.jpg)
Tidak perlu lagi kemas kini status COVID-19 dalam MySejahtera - KKM
Jika positif COVID-19 melalui ujian kendiri, pesakit boleh mengunjungi klinik dan hospital berdekatan bagi mendapatkan pengesahan.
![Mayat hampir reput dijumpai di rumah usang Mayat hampir reput dijumpai di rumah usang](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2023-12/41702437730_maut.jpg)
Mayat hampir reput dijumpai di rumah usang
Mayat hampir reput ditemui di sebuah rumah usang di Kesang Laut, berdekatan pusat timbang Jabatan Pengangkutan Jalan (JPJ) pada Ahad.
Wanita dakwa dituduh Rafizi fail saman
Seorang wanita memfailkan saman terhadap Menteri Ekonomi, Rafizi Ramli bagi menuntut permohonan maaf secara terbuka berhubung dakwaan bahawa wanita berkenaan ialah isteri kepada bekas menteri yang dikaitkan dengan isu kapal tempur pesisir (LCS).
Bagaimanapun, Rafizi bergantung kepada pembelaan justifikasi berkata bersedia membuktikan kenyataan di mahkamah termasuk perlindungan bersyarat dan ulasan yang saksama terhadap saman fitnah yang difailkan oleh Zainab Mohd Salleh.
Bagaimanapun, Rafizi bergantung kepada pembelaan justifikasi berkata bersedia membuktikan kenyataan di mahkamah termasuk perlindungan bersyarat dan ulasan yang saksama terhadap saman fitnah yang difailkan oleh Zainab Mohd Salleh.
![Ahli Parlimen PN pakai reben putih di lengan tak langgar peraturan - Timbalan Speaker Ahli Parlimen PN pakai reben putih di lengan tak langgar peraturan - Timbalan Speaker](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/61721011336_PerikatanNasional.jpg)
Ahli Parlimen PN pakai reben putih di lengan tak langgar peraturan - Timbalan Speaker
Jelas Timbalan Yang Dipertua Dewan Rakyat itu, pendirian tersebut adalah keputusannya dan ia tidak dibuat oleh Yang Dipertua Dewan Rakyat, Tan Sri Johari Abdul.
![Trump umum Senator JD Vance sebagai calon Naib Presidennya Trump umum Senator JD Vance sebagai calon Naib Presidennya](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/81721104956_JDVance.jpg)
Trump umum Senator JD Vance sebagai calon Naib Presidennya
Bekas Presiden Amerika Syarikat Donald Trump mengumumkan Senator Ohio JD Vance akan menjadi calon Naib Presidennya dalam pilihan raya 2024.
AWANI Ringkas: Pan Gon bakal umum letak jawatan hari ini?
Ikuti rangkuman berita utama yang menjadi tumpuan sepanjang hari di Astro AWANI menerusi AWANI Ringkas.
![iOS 18 tampil ciri kembalikan gambar, video yang hilang atau rosak iOS 18 tampil ciri kembalikan gambar, video yang hilang atau rosak](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/81721103714_iOS.jpg)
iOS 18 tampil ciri kembalikan gambar, video yang hilang atau rosak
Pada iOS 18, iPadOS 18 dan macOS Sequoia, Apple memperkenalkan ciri baharu yang membolehkan data yang hilang ini dikembalikan.
[TERKINI] Suspek kes pempengaruh Esha mengaku bersalah
Seorang pemandu lori berusia 43 tahun mengaku bersalah membuat kenyataan menyinggung perasaan terhadap mendiang empengaruh media sosial, A Rajeswary atau Esha di TikTok.
Projek HSR Jakarta-Bandung rekod 4 juta penumpang
Projek Kereta Api Laju (HSR) Jakarta-Bandung yang dikenali sebagai Whoosh membawa empat juta penumpang sejak ia beroperasi secara komersial pada 17 Oktober, tahun lalu.